AnaptysBio, Inc.AnaptysBio, Inc.AnaptysBio, Inc.

AnaptysBio, Inc.

No trades
See on Supercharts

Price target

46.000.00 0.00%
The 9 analysts offering 1 year price forecasts for ANAB have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to ANAB in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ANAB EPS for the last quarter is −1.59 USD despite the estimation of −1.60 USD. In the next quarter EPS is expected to reach −1.57 USD. Track more of AnaptysBio, Inc. financials and stay on top of what is up with the company.
In the next quarter AnaptysBio, Inc. revenue is expected to reach ‪3.76 M‬ USD. Check out AnaptysBio, Inc. revenue and earnings and make informed decisions.
According to analysts, ANAB price target is 46.00 USD with a max estimate of 80.00 USD and a min estimate of 20.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ANAB news and stock market news.
We've gathered opinions of 10 analysts rating ANAB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.